Диссертация (1173257), страница 20
Текст из файла (страница 20)
Lagana, SG. Vitale, FM. Salmeri, etal. // Med Hypotheses. – 2017. – N. 103. – P. 10-20.126. Lemos, N.A. Decreased AMH and altered ovarian follicular cohort in infertilepatients with mild/minimal endometriosis / N.A. Lemos, E. Arbo, R. Scalco, E.
Weiler,V. Rosa, J.S. Cunha-Filho // Fertil Steril. – 2008. – N. 89. – P. 1064-8.127. Liu, L. 17β-estradiol attenuates ovariectomy induced bone deterioration throughthe suppression of the ephA2/ephrinA2 signaling pathway / L. Liu, L. Zhou, X. Yang,Q. Liu, L. Yang, C. Zheng, Y. Zhao, Z. Zhang, X. Luo // Mol Med Rep. – 2018. –Vol. 14, N. 17(1). – P. 1609-1616.117128. Lindsay, R. Estrogens, Progestins, SERMs, and Osteoporosis / R. Lindsay //Nutrition and Bone Health.
– 2015. – P. 57-63.129. Matalliotakis, M. Retrospective evaluation of pathological results among womenwith ovarian endometriomas versus teratomas / M. Matalliotakis, C. Matalliotaki,M.I. Zervou, K. Krithinakis, G.N. Goulielmos, et al. // Molecular and ClinicalOncology.
– 2019. – Vol. 10, N. 6. – P. 592-596.130. Matalliotaki, C. Co-existence of benign gynecological tumors with endometriosisin a group of 1,000 women / C. Matalliotaki, M. Matalliotakis, P. Ieromonachou,G.N. Goulielmos, M.I. Zervou, A. Laliotis, D.A. Spandidos, A. Arici, I. Matalliotakis //Oncol Lett. – 2018. – N. 15. – P. 1529-1532.131.
Mircea, O. Fertility outcomes after ablation using plasma energy versus cystectomy ininfertile women with ovarian endometrioma: a multicentric comparative study / O. Mircea,L. Puscasiu, B. Resch, J. Lucas, et al. // J. Minim. Invasive Gynecol. – 2016. – Vol. 23,N. 7. – P. 1138-1145.132. Mozzanega, B. Cyclic variations of bone resorption mediators and markers in thedifferent phases of the menstrual cycle / B. Mozzanega, S. Gizzo, D.
Bernardi,L. Salmaso, T.S. Patrelli, R. Mioni, L. Finos, G.B. Nardelli // Journal of Bone andMineral Metabolism. – 2013. – Vol. 31, N. 4. – P. 461-467.133. Muzii, L. Infertility associated with ovarian endometriomas: surgery or in-vitrofertilization? / L. Muzii, C.D. Tucci, M.D. Feliciantonio, et al. // In Vitro Fertilization. –2017. – Vol. 1, N. 1. – P. 1-3.134. Naylor, K.E.
Eastell Response of bone turnover markers to three oralbisphosphonate therapies in postmenopausal osteoporosis: the TRIO study /K.E. Naylor, R.M. Jacques, M. Paggiosi, et al. // Osteoporos Int. – 2016. – Vol. 27,N. 1. – P. 21-31.135. Nitta, K. Management of osteoporosis in chronic kidney disease / K. Nitta,A. Yajima, K.
Tsuchiya // Intern Med. – 2017. – N. 56. – P. 3271-3276.136. Nieweglowska, D. Age-related trends in anti-Mullerian hormone serum level inwomen with unilateral and bilateral ovarian endometriomas prior to surgery /118D. Nieweglowska, I. Hajdyla-Banas, K. Pitynski, et al. // Reprod Biol Endocrinol. –2015. – N. 13:128. doi:10.1186/s12958-015-0125-x.137. Nowak-Psiorz, I. Treatment of ovarian endometrial cysts in the context ofrecurrence and fertility / I. Nowak-Psiorz, S.M.
Ciećwież, A. Brodowska,A. Starczewski // Adv Clin Exp Med. – 2019. – Vol. 28, N. 3. – P. 407-413.138. Nwosu, L.N. Pain prediction by serum biomarkers of bone turnover in people withknee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA /L.N. Nwosu, M. Allen, L. Wyatt, et al. // Osteoarthritis and Cartilage. – 2017. – Vol. 25,N. 6. – P. 858-865.139.
Obermayer-Pietsch, B. Biochemische Marker des Knochenstoffwechsels und ihreBedeutung / B. Obermayer-Pietsch, V. Schwetz // Zeitschrift für Rheumatologie. –2016. – Vol. 75, N. 5. – P. 451-458.140. Ochiai, K. A retrospective study of 1069 epithelial borderline malignancies of theovary treated in Japan / K. Ochiai, H. Shinozaki, et al. Proceedings of the AnnualMeeting of the American Society of Clinical Oncology.
1998; 17:A1429.141. Park, SY. Clinical Application of Bone Turnover Markers in Osteoporosis inKorea / SY Park, SH Ahn, JI. Yoo, YJ. Chung, YK. Jeon, BH. Yoon, HY Kim,SH. Lee, J. Lee, S. Hong // J Bone Metab. – 2019. – Vol.26, N.1. – P. 19-24.142. Perlman, S. Ovarian damage due to cyst removal: a comparison of endometriomas anddermoid cysts / S. Perlman, JJ. Kjer // Acta Obstet Gynecol Scand. – 2016. – N. 95.
–P. 285-290.143. Pisani, P. An innovativeultrasound-based method for the identification of patientsat high fracture risk / P. Pisani, A. Greco, M. Renna, F. Conversano, E. Casciaro,L. Quarta // JIET Science, Measurement & Technology. – 2014. – N. 1.
– Р. 50-53.144. Prior, JC. Progesterone as a bone-trophic hormone / JC. Prior // Endocr Rev. –1990. – Vol. 11, N. 2. – P. 386-398.145. Popat, V.B. Bone Mineral Density in Young Women With Primary OvarianInsufficiency: Results of a Three-Year Randomized Controlled Trial of PhysiologicalTransdermal Estradiol and Testosterone Replacement / V.B. Popat, K.A. Calis,S.N. Kalantaridou, V.H. Vanderhoof, D. Koziol, J.F. Troendle, J.C. Reynolds,119L.M. Nelson // The Journal of Clinical Endocrinology & Metabolism. – 2014. – Vol.
99,N. 9. – P. 3418-3426.146. Raffi, F. The impact of excision of ovarian endometrioma on ovarian reserve: asystematic review and metaanalysis / F. Raffi, M. Metwally, S. Amer // J. Clin.Endocrinol. Metab. – 2012. – Vol. 97, N. 9. – P. 3146-3154.147. Rakhila, H. Promotion of angiogenesis and proliferation cytokines patterns inperitoneal fluid from women with endometriosis / H. Rakhila, M. Al-Akoum,M.E.
Bergeron, M. Leboeuf, M. Lemyre, A. Akoum, M. Pouliot // J. Reprod. Immunol. –2016. – N. 116. – P. 1-6.148. Riccio, L.G.C. The role of the B lymphocytes in endometriosis: A systematic review /L.G.C. Riccio, E.C. Baracat, C. Chapron, et al. // J. Reprod. Immunol. – 2017. –Vol. 123. – P. 29-34.149. Sanchez, A.M. The distinguishing cellular and molecular features of theendometriotic ovarian cyst: From pathophysiology to the potential endometriomamediated damage to the ovary / A.M. Sanchez, P.
Vigano, E. Somigliana, P. PaninaBordignon, P. Vercellini, M. Candiani // Hum.Reprod. Update. – 2014. – N. 20. –P. 217-230.150. Santulli, P. Endometriosis-related infertility: ovarian endometrioma per se is notassociated with presentation for infertility / P. Santulli, M.C. Lamau, L. Marcellin, et al. //Hum. Reprod. – 2016. – Vol. 31, N. 8.
– P. 1765-1775.151. Sato, F. Familial aggregation of uterine myomas in Japanese women / F. Sato,M. Mori, M. Nishi, R. Kudo, H. Miyake // J Epidemiol. – 2002. – Vol. 12, N. 3. –P. 249-53.152. Shea, KL. Body composition and bone mineral density after ovarian hormonesuppression with or without estradiol treatment / KL. Shea, KM. Gavin, EL. Melanson,et al.
// Menopause. – 2015. – Vol. 22, N. 10. – P. 1045-1052.153. Shi, L.B. Transforming growth factor beta1 from endometriomas promotes fibrosisin surrounding ovarian tissues via Smad2/3 signaling / L.B. Shi, F. Zhou, H.Y. Zhu,D. Huang, X.Y. Jin, C. Li, Y. Dai, Y.B. Pan, S.Y. Zhang // Biol Reprod. – 2017. –N. 97. – P. 873-882.120154. Singh, R. Differential effect of predictors of bone mineral density and hip geometry inpostmenopausal women: a cross-sectional study / R. Singh, S. Gupta, A. Awasthi //Archives of Osteoporosis.
https://doi.org/10.1007/s11657-015-0246-z– 2015155. Svoboda, S.J. The Association between Serum Biomarkers of Collagen Turnoverand Subsequent Anterior Cruciate Ligament Rupture / S.J. Svoboda, B.D. Owens,T.M. Harvey, P.M. Tarwater, W.F. Brechue // The American Journal of SportsMedicine. – 2016. – Vol. 44, N. 7. – P. 1687-1693.156.
Tinelli, R. Conservative surgery for borderline ovarian tumors: a review /R. Tinelli, A. Tinelli, F.G. Tinelli, E. Cicinelli, A. Malvasi // Gynecol. Oncol. – 2006. –Vol. 100, N. 1. – Р. 185-191.157. Takashi, Y. Circulating osteocalcin as a bone-derived hormone is inversely correlatedwith body fat in patients with type 1 diabetes / Y. Takashi, M.
Ishizu, H. Mori,K. Miyashita,F.Sakamoto,N.Katakami,etal.https://doi.org/10.1371/journal.pone.0216416.158. Trillsch, F. Clinical management of borderline ovarian tumors / F. Trillsch,S. Mahner, J.D. Ruetzel, P. Harter, D. Ewald-Riegler, J.
Jaenicke, et al. // Expert Rev.Anticancer Ther. – 2010. – Vol. 10, N. 7. – Р. 1115-1124.159. Wang X, Diao L, Sun D, Wang D, Zhu J, He Y, Liu Y, Xu H, Zhang Y, Liu J,Wang Y, He F, Li Y, Li D. 2019. OsteoporosAtlas: a human osteoporosis-related genedatabase. PeerJ 7:e6778 https://doi.org/10.7717/peerj.6778.160. Wei, W. Bone mineral density during pregnancy in women participating in arandomized controlled trial of vitamin D supplementation / W.
Wei, JR. Shary,E. Garrett-Mayer, et al. // The American Journal of Clinical Nutrition. – 2017. –Vol. 106, N. 6. – P. 1422-1430.161. Yoo, J.I. Age-related reference intervals for total collagen-I-N-terminal propeptidein healthy Korean population / J.I. Yoo, A.J. Park, Y.K. Lim, et al. // J Bone Metab. –2018. – N.
25. – P. 235-241.162. Yoon, B.K. Effects of Combination Therapy of Alendronate and HormonalTherapy on Bone Mineral Density in Postmenopausal Korean Women: Multicenter,121Randomized Controlled Clinical Trial / B.K. Yoon, D.Y. Lee, M.C. Park, S.H. Cho,H.M. Park, Y.M. Choi // J Korean Ved Sci. – 2017. – Vol. 32, N.
6. – P. 992-998.163. Zanelotti, A. Surgery and endometriosis / A. Zanelotti, A.H. Decherney // ClinObstet Gynecol. – 2017. – N. 60. – P. 477-484.164. Zhao, W. MiR-21 overexpression improves osteoporosis by targeting RECK / W.Zhao, Y. Dong, C. Wu, Y. Ma, Y. Jin, Y. Ji // Molecular and Cellular Biochemistry. –2015. Vol. – 405. – Issue (1–2). – P. 125-133..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
